Valuation: Rohto Pharmaceutical Co.,Ltd.

Market Cap 636B 4B 3.45B 3.24B 2.95B 5.55B 382B 5.64B 38.02B 14.87B 191B 15.01B 14.68B P/E 2027 *
18.2x
P/E 2028 * 17x
Enterprise Value 575B 3.61B 3.12B 2.93B 2.67B 5.01B 345B 5.1B 34.36B 13.43B 173B 13.56B 13.27B EV / Sales 2027 *
1.55x
EV / Sales 2028 * 1.44x
Free-Float
84.69%
Yield 2027 *
1.78%
Yield 2028 * 1.83%
1 day-1.39%
1 week-1.82%
Current month+16.24%
1 month+12.07%
3 months+13.81%
6 months+13.91%
Current year+5.65%
1 week 2,757.5
Extreme 2757.5
2,862.5
1 month 2,285
Extreme 2285
2,918.5
Current year 2,218.5
Extreme 2218.5
2,918.5
1 year 2,218.5
Extreme 2218.5
2,918.5
3 years 1,964.5
Extreme 1964.5
4,117
5 years 1,515
Extreme 1515
4,117
10 years 762
Extreme 762
4,117
Manager TitleAgeSince
Chief Executive Officer 70 2019-05-31
President 64 2025-06-25
Director of Finance/CFO 62 2022-02-28
Director TitleAgeSince
Chairman 70 2009-05-31
Director/Board Member 70 2010-05-31
Director/Board Member 62 2011-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.39%-1.82%+12.23%-24.96% 4B
-2.25%-0.47%+68.30%+116.05% 1,052B
-0.66%+0.43%+47.39%+51.02% 627B
-0.54%+1.39%+20.69%+64.61% 441B
-1.99%-3.32%+38.71%+36.26% 349B
-1.05%-2.81%+23.07%+35.91% 287B
-2.12%-3.67%-1.14%+5.35% 241B
-0.63%+1.04%+40.05%+56.67% 224B
-1.19%-3.41%-9.57%-53.50% 202B
+0.16%+3.87%+16.89%+77.38% 172B
Average -1.17%+2.26%+25.66%+36.48% 359.92B
Weighted average by Cap. -1.36%+0.07%+39.06%+61.66%

Financials

2027 *2028 *
Net sales 371B 2.33B 2.01B 1.89B 1.72B 3.24B 223B 3.29B 22.18B 8.67B 112B 8.75B 8.56B 385B 2.42B 2.09B 1.97B 1.79B 3.36B 232B 3.42B 23.03B 9B 116B 9.09B 8.89B
Net income 35.02B 220M 190M 179M 162M 305M 21.04B 310M 2.09B 818M 10.54B 826M 808M 37.47B 235M 203M 191M 174M 327M 22.52B 332M 2.24B 876M 11.28B 884M 865M
Net Debt -61.32B -385M -333M -313M -284M -535M -36.85B -544M -3.66B -1.43B -18.45B -1.45B -1.42B -80.92B -509M -439M -413M -375M -706M -48.63B -717M -4.84B -1.89B -24.35B -1.91B -1.87B
Logo Rohto Pharmaceutical Co.,Ltd.
Rohto Pharmaceutical Co Ltd is a Japan-based company primarily engaged in the manufacture and sale of eye care (eye drops, eyewash), skin care (external medications, lip balm, sunscreen, functional cosmetics), oral medication (gastrointestinal medicines, herbal medicines, supplements), and other products and services (in vitro diagnostic reagents) in the health and beauty care field. The Company operates through four regional segments. The Japan segment manufactures and sells eye care, skin care, oral medication, and other products (services). The Americas segment and the Europe segment mainly manufacture and sell skin care products (services). The Asia segment mainly manufactures and sells eye care and skin care products (services), as well as oral medication products (services).
Employees
9,292
Date Price Change Volume
26-08-16 JP¥2,776.50 -1.39% 270,600
26-08-14 JP¥2,815.50 -0.90% 915,600
26-08-13 JP¥2,841.00 -0.32% 1,139,400
26-08-12 JP¥2,850.00 +0.78% 1,719,900
26-08-10 JP¥2,828.00 -1.21% 3,402,500
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
2,815.50JPY
Average target price
2,975.45JPY
Spread / Average Target
+5.68%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4527 Stock